Your browser doesn't support javascript.
Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options.
Khan, Suliman; Siddique, Rabeea; Bai, Qian; Liu, Yang; Xue, Mengzhou; Nabi, Ghulam; Liu, Jianbo.
  • Khan S; The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China. Electronic address: Suliman.khan18@mails.ucas.ac.cn.
  • Siddique R; The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China.
  • Bai Q; The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China.
  • Shabana; Key State Laboratory of Virology, School of Life Sciences, Wuhan University, Wuhan, China.
  • Liu Y; The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China.
  • Xue M; The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China. Electronic address: xuemengzhou@zzu.edu.cn.
  • Nabi G; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang 050024, China. Electronic address: ghulamnabiqau@gmial.com.
  • Liu J; Department of Respiratory Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: jbliuzz@zzu.edu.cn.
J Infect Public Health ; 13(12): 1840-1844, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1023642
ABSTRACT
Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine, fatalities and morbidities are increasing day by day globally. Despite physical health consequences, COVID-19 pandemic has created stress and anxiety, as result there is an increased risk of mental illnesses both in the infected and normal individuals. To eradicate these risks, it is necessary to determine the COVID-19 zoonotic source of transmission to humans and clinical manifestations in infected individuals. Although, identification or development of the highly effective therapeutic agents is necessary, however, development of protective strategies against the COVID-19 by enhancing immune responses will be an asset in the current scenarios of the COVID-19 pandemic. In this paper, we discuss the transmission, health consequences, and potential management (therapeutic and preventive) options for COVID-19 disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Mental Disorders Type of study: Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Mental Disorders Type of study: Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2020 Document Type: Article